─── A Think Tank for Smart Vaccine Cold Chain in China
From manufacturingto defining the futureof the industry
We use data, research and global benchmarks to define the next decade of China’s vaccine cold chain. Annual whitepapers, AI + digital twin foresight, and side-by-side comparisons with WHO, Gavi and UNICEF systems put every decision on higher ground.
Editorial Brief
Within ten years, vaccine cold chain will undergo a second transformation
The first transformation moved vaccines from −20 °C bulk freezers to standardized +2~8 °C industrial chains. The second is now under way: from mechanical refrigeration to AI-driven, fully sensed smart cold chains.
By the VaxFuture editorial board
─── Institute baseline · as of Q2 2026
─── Q2 2026
Featured research
Digital Twin Vaccine Warehouse: From Mechanical Control to Full-Element Simulation
When a vaccine warehouse can be mirrored as a nanometer-resolution digital twin, it ceases to be merely a monitored asset and becomes a reasoning, forecasting, decision-capable cold room. This article maps the three architectural layers of digital twin warehouses and proposes Mingyuan’s five-year, three-stage engineering path.
LLM Agents in Vaccine Management: From Chatbot to Full-Process Digital Worker
In the past 18 months LLM systems evolved from chatbots into multi-step agents. This article uses three scenarios to show how LLM agents can deliver real engineering value on the vaccine management front line: smart replenishment, root-cause analysis and multimodal vision collaboration.
China Vaccine Cold Chain 2030: Twelve High-Confidence Predictions
This article presents twelve high-confidence predictions for the next five years. Each prediction includes observable early signals and a quantitative checkpoint. Not science fiction — an engineering forecast that can be audited.
─── Vol. 01 / 2026
China Vaccine Cold Chain Intelligence Whitepaper 2026
From Mechanical Control to AI-Sensed Smart Cold Chain: An Engineering Blueprint for the Second Revolution
This whitepaper (in drafting, planned release Q2 2026) reviews the current state, bottlenecks and discussable future pathways of vaccine cold chain intelligence in China. Data sources include anonymized records of verified Mingyuan projects in the institute case library, public-source syntheses of eight global systems, and internal research-team workshops. The paper will propose a triadic technical discussion framework ("digital twin + AI inspection + federated emergency"). All forecasts carry explicit verification criteria, open for reader audit by 2030.
- 01China’s vaccine cold chain is approaching the transition between mechanical and smart cold chain, propelled by multiple converging forces
- 02Per-warehouse digital twin cost is on a declining trajectory; exact annual target ranges will be updated each year in the whitepaper
- 03Smart replenishment shows structural improvement space over rule-based systems when combining structured and unstructured signals (exact figures per partner disclosures)
─── International Benchmarks
Global benchmark studies
Side-by-side comparisons with WHO, Gavi, UNICEF, CDC USA and EU vaccine cold chain systems, distilling best practices that can be localized to China.
World Health Organization
Global standards and pre-qualification for vaccine cold chain equipment
Gavi, the Vaccine Alliance
Investment and operations of vaccine cold chains in low-income countries
UNICEF
Last-mile vaccine cold chain
CDC USA
US national immunization program cold chain
European Union
EU pharmaceutical cold chain regulation
WHO
Emergency Use Listing
IPV Coalition
Inactivated Polio Vaccine supply chain
DHIS2 / HISP
Open-source immunization information system platform
─── Observatory · Biweekly
Observatory · biweekly briefing
A curated biweekly briefing on global tech, policy and business model shifts — delivered straight to decision makers.
→ Subscribe- 2026-04-08 · 技术
Edge AI inference appliance pricing trend (#01)
Over recent months, mainstream edge AI inference appliances have seen continued price declines, driven by NPU supply normalization, growing domestic vendor share and concentrated demand around a handful of standard form factors. Institute view: for county-level CDCs in mid-term procurement planning, the priority is not "wait for further discounts" but "write tender specs flexible enough to accommodate the next 2-3 years of mainstream form factors". Readers who need specific quarterly pricing ranges should consult current-year market research reports (IDC, Gartner, CCID, etc.); the institute does not publish unverified specific percentages.
- 2026-03-25 · 政策
Vaccine Administration Law implementation rules tracking (#00)
Chinese health authorities are advancing implementation rules for the Vaccine Administration Law. Institute focus: temperature monitoring granularity, process-replayability implementation pathways, and comparisons with EU GDP 2013 "excursion-as-root-cause-analysis" mechanisms. For the latest text, readers should consult official websites of the National Health Commission and NMPA. This note does not represent any legislative forecast.
─── Join the network
The future of the Institute is written together
We welcome policy researchers, CDC peers, pharma strategy teams, investors, university faculty, think tank fellows and international organization representatives to join our research network.